Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-008044
Filing Date
2024-11-14
Accepted
2024-11-14 11:38:52
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FROM 10-Q FOR SEPT 2024 bioregenx_i10q-093024.htm   iXBRL 10-Q 931032
2 CERTIFICATION bioregenx_ex3100.htm EX-31 6990
3 CERTIFICATION bioregenx_ex3200.htm EX-32 3146
  Complete submission text file 0001683168-24-008044.txt   6109480

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE brgx-20240930.xsd EX-101.SCH 48483
5 XBRL CALCULATION FILE brgx-20240930_cal.xml EX-101.CAL 53146
6 XBRL DEFINITION FILE brgx-20240930_def.xml EX-101.DEF 260198
7 XBRL LABEL FILE brgx-20240930_lab.xml EX-101.LAB 394936
8 XBRL PRESENTATION FILE brgx-20240930_pre.xml EX-101.PRE 368411
75 EXTRACTED XBRL INSTANCE DOCUMENT bioregenx_i10q-093024_htm.xml XML 912715
Mailing Address 7407 ZIEGLER ROAD CHATTANOOGA TN 37421
Business Address 7407 ZIEGLER ROAD CHATTANOOGA TN 37421 (866) 770-4067
BIOREGENX, INC. (Filer) CIK: 0001593184 (see all company filings)

EIN.: 462836541 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56345 | Film No.: 241458888
SIC: 7370 Services-Computer Programming, Data Processing, Etc.
(CF Office: 06 Technology)